Foravirumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Foravirumab
Monoclonal antibody
Type Whole antibody
Source Human
Target rabies virus glycoprotein
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
ChEMBL
Chemical and physical data
Formula C6400H9914N1718O1998S44
Molar mass 144.3 kg/mol
 NYesY (what is this?)  (verify)

Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]

References[edit]

  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
  2. ^ Khardori, Nancy Misri (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 9781455712076.